Sanofi Channel Stuffing In Brazil?
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi CEO Chris Viehbacher showed clear signs of disappointment during the company’s earnings call, admitting emerging markets underperformed, and revealing a debacle in Brazil that appears to be channel stuffing.
You may also be interested in...
Sanofi Says Pfizer’s PCSK9 Phase III Plan Will Boost The New Drug Class
Sanofi CEO Christopher Viehbacher seemed unperturbed by Pfizer’s ambitious PCSK9 Phase III development program, saying it will increase interest in the new drug class.
Sanofi Says Pfizer’s PCSK9 Phase III Plan Will Boost The New Drug Class
Sanofi CEO Christopher Viehbacher seemed unperturbed by Pfizer’s ambitious PCSK9 Phase III development program, saying it will increase interest in the new drug class.
Sanofi Is Composing Emerging Markets Strategy: Latest Acquisition Is Brazilian Medley For $686M
Sanofi’s acquisition of Medley, Brazil’s largest generics company, reinforces its increasingly aggressive expansion in emerging markets.